IMAGE: Lung squamous cell carcinoma

Breaking News

Key: Meeting M      Journal J      Funder F

Showing releases 26-50 out of 1299.

<< < 1 | 2 | 3 | 4 | 5 | 6 > >>

Public Release: 20-Nov-2015
Nanomedicine special issue explores integrated role of nanomedical research
Nanomedicine, a leading MEDLINE-indexed journal, has published a special focus issue highlighting the interdisciplinary nature of this emerging field, which explores the medical application of nanotechnology to monitor, repair, and control human biological systems at the molecular level. Nanomedicine is published by Future Science Group.

Contact: Leela Ripton
Future Science Group

Public Release: 20-Nov-2015
Journal of the National Cancer Institute
Tumor-suppressor p53 regulates protein that stifles immune attack on cancer
A crucial tumor-thwarting gene protects an immune attack against lung cancer by blocking the key to an off switch on T cells, the customized warriors of the immune system, a team led by researchers at The University of Texas MD Anderson Cancer Center reports in the Journal of the National Cancer Institute.

Contact: Scott Merville
University of Texas M. D. Anderson Cancer Center

Public Release: 19-Nov-2015
Sensory illusion causes cells to self-destruct
UCSF researchers has discovered that even brainless single-celled yeast have sensory biases that can be hacked by a carefully engineered illusion, a finding that could be used to develop new approaches to fighting diseases such as cancer.

Contact: Nicholas Weiler
University of California - San Francisco

Public Release: 19-Nov-2015
Seminars in Cancer Biology
UAEU researchers as part of a global task force re-address untreatable cancers & disease relapse
UAEU scientists in collaboration with colleagues from top tier institutions such as Harvard, MIT, Berkeley, Stanford and John Hopkins were put together by a Canadian NGO called 'Getting to Know Cancer'. Interdisciplinary teams nominated a series of high-priority molecular targets that could be reached with chemicals to improve patient outcomes in most cancers. Candidates for mixtures of natural-based chemicals with potential to reach a broad-spectrum of priority targets in most cancer types were recommended.

Contact: Amr A. Amin
United Arab Emirates University

Public Release: 19-Nov-2015
JAMA Oncology
Studies examine long-term outcomes in childhood, young adult cancer survivors
JAMA Oncology published two studies and a related editorial focused on long-term outcomes in survivors of childhood or young adult cancer.

Contact: Kathrine Rugbjerg
The JAMA Network Journals

Public Release: 19-Nov-2015
Applied Catalysis B Environmental
Better catalysts will remove carcinogenic chlorine compounds from water
The Institute of Physical Chemistry of the Polish Academy of Sciences in Warsaw has just unveiled two new catalysts developed in close cooperation with the Jagiellonian University in Cracow and the Jan Kochanowski University in Kielce. The catalysts have been designed with the effective treatment of tap water in mind, eliminating harmful chlorine compounds.

Contact: Dr. Anna Srebowata
Institute of Physical Chemistry of the Polish Academy of Sciences

Public Release: 19-Nov-2015
Cancer Cell
Researchers develop model to study, find ways to target rare tumor
Cancer researchers at the University of Cincinnati (UC) have found a new target that could lead to therapies for a rare type of tumor. These findings are being reported in the Nov. 9 advance online edition of the journal Cancer Cell.
National Institutes of Health

Contact: Katie Pence
University of Cincinnati Academic Health Center

Public Release: 19-Nov-2015
Cancer Epidemiology, Biomarkers & Prevention
Possible new mechanism for aspirin's role in cancer prevention
In a study published in the journal of Cancer Epidemiology, Biomarkers, and Prevention, Cornelia Ulrich from Huntsman Cancer Institute and her collaborators used a new technique, metabolite profiling, to identify a biochemical pathway previously unknown to be regulated by aspirin. Specifically, the researchers found that aspirin substantially decreases the level of a chemical called 2-hydroxyglutarate in the blood of healthy volunteers and in two colorectal cancer cell lines.
National Institutes of Health, Huntsman Cancer Foundation, German Cancer Research Center

Contact: Linda Aagard
University of Utah Health Sciences

Public Release: 19-Nov-2015
Journal of Controlled Release
Nanocarriers may carry new hope for brain cancer therapy
Berkeley Lab researchers have developed a new family of nanocarriers, called '3HM,' that meets all the size and stability requirements for effectively delivering therapeutic drugs to the brain for the treatment of a deadly form of cancer known as glioblastoma multiforme.
National Institutes of Health

Contact: Lynn Yarris
DOE/Lawrence Berkeley National Laboratory

Public Release: 19-Nov-2015
Intelligent gel attacks cancer
A new injectable 'biogel' is effective in delivering anti-cancer agents directly into cancerous tumors and killing them. This technology, developed by researchers at the University of Montreal Hospital Research Centre, has already been successfully tested in the laboratory. If it works in patients, the therapy could one day revolutionize treatment for many forms of cancer.

Contact: Isabelle Girard
University of Montreal Hospital Research Centre (CRCHUM)

Public Release: 19-Nov-2015
Cell Reports
UTSW research finding could lead to targeted therapies for inflammatory bowel diseases
UT Southwestern Medical Center researchers have shown that a pathogen-sensing molecule plays a vital role in keeping gastrointestinal systems healthy.
Crohn's and Colitis Foundation, American Cancer Society

Contact: Debbie Bolles
UT Southwestern Medical Center

Public Release: 19-Nov-2015
Personalized drug screening on horizon for multiple myeloma patients
A personalized method for testing the effectiveness of drugs that treat multiple myeloma may predict quickly and more accurately the best treatments for individual patients with the bone marrow cancer. The process, developed by scientists at Washington University School of Medicine in St. Louis, also may aid patients with leukemia or lymphoma.

Contact: Jim Goodwin
Washington University School of Medicine

Public Release: 19-Nov-2015
Cancer Research
Scientists find way to make resistant brain cancer cells sensitive to treatment
Robert Gourdie and his research team developed a peptide called aCT1 (pronounced act one) to inhibit connexin 43-caused overactivity. The result was damaged tissue healed more quickly, with lower amounts of inflammation and scarring.

Contact: Paula Byron
Virginia Tech

Public Release: 19-Nov-2015
Women's Health Issues
Study: Risk of undetected cancer in gynecologic surgery higher than previously thought
A Boston Medical Center study revealed that 1 in 352 women had an unsuspected cancer at the time of gynecologic surgery for disease that was thought to be benign. The study is published online in advance of print in the journal Women's Health Issues.
American Cancer Society

Contact: Elissa Snook
Boston University Medical Center

Public Release: 18-Nov-2015
Lancet Haematology
Late effects of treatment study continues sustained academic effort in Hodgkin's lymphoma
'These study results are exciting. They should allow physicians to optimize the combination of systemic therapy and radiation and thereby balance the risks and benefits of different regimens in individual patients.'

Contact: John Bean
European Organisation for Research and Treatment of Cancer

Public Release: 18-Nov-2015
Scientific Reports
Technique to more effectively diagnose and treat cancer developed by Georgia State University
A method to better trace changes in cancers and treatment of the prostate and lung without the limitations associated with radiation has been developed by Georgia State University researchers.

Contact: Brian Mullen
Georgia State University

Public Release: 18-Nov-2015
Seminars in Cancer Biology
Global task force tackles problem of untreatable cancers and disease relapse 
Combinations of a significant number of non-toxic substances, many of which can be found in plants and foods, may give us a chance to stop untreatable cancers and prevent disease.

Contact: Leroy Lowe
Saarland University

Public Release: 18-Nov-2015
New England Journal of Medicine
Why do children develop cancer?
As new scientific discoveries deepen our understanding of how cancer develops in children, doctors and other healthcare providers face challenges in better using that knowledge to guide treatment and counsel families and patients. A CHOP pediatric oncologist offers expert commentary on a major study of cancer predisposition genes in children being published today, and outlines areas for further investigation.

Contact: John Ascenzi
Children's Hospital of Philadelphia

Public Release: 18-Nov-2015
One very brainy bird
A joint study by the University of Iowa and University of California-Davis found pigeons performed as well as humans in categorizing digitized slides and mammograms of benign and malignant human breast tissue. Results published in the journal PLOS ONE.
National Institutes of Health

Contact: Richard Lewis
University of Iowa

Public Release: 18-Nov-2015
Proceedings of the National Academy of Sciences
Mutations in key cancer protein suggest new route to treatments
Researchers found they could disrupt STAT3's ability to act as a transcription factor by altering part of the protein, which interfered with its cancer-promoting activity. The findings suggest a basis for new, targeted approaches to fighting cancer.

Contact: Katherine Fenz
Rockefeller University

Public Release: 18-Nov-2015
Current Biology
Marine animals use new form of secret light communication
Researchers from the Queensland Brain Institute at The University of Queensland have uncovered a new form of secret light communication used by marine animals. The findings may have applications in satellite remote sensing, biomedical imaging, cancer detection, and computer data storage.
Air Force Office of Scientific Research, Asian Office of Aerospace Research and Development, Australian Research Council

Contact: Bernadette Condren
University of Queensland

Public Release: 18-Nov-2015
Biotechnology Journal
Chemical engineers have figured out how to make vaccines faster
Researchers at Brigham Young University have devised a system to speed up the process of making life-saving vaccines for new viruses. Their concept is to create the biological machinery for vaccine production en masse, put it in a freeze-dried state and stockpile it around the country. Then, when a new virus hits, labs can simply add water to a 'kit' to rapidly produce vaccines.
National Science Foundation, Defense Advanced Research Projects Agency

Contact: Todd Hollingshead
Brigham Young University

Public Release: 18-Nov-2015
International Society of Neurogastronomy Symposium
Neurogastronomy: How our brains perceive the flavor of food
Neuroscientists, food scientists and internationally renowned chefs convened at the University of Kentucky recently to explore ways to help patients with neurologically related taste impairments enjoy food again.

Contact: Laura Dawahare
University of Kentucky

Public Release: 18-Nov-2015
Breast Cancer Research and Treatment
Without prescription coverage, some cancer patients do without even low-cost drugs
A University of Colorado Cancer Center study published in the journal Breast Cancer Research and Treatment shows that breast cancer patients whose health insurance plans included prescription drug benefits were 10 percent more likely to start important hormonal therapy than patients who did not have prescription drug coverage. Women with household income below $40,000 were less than half as likely as women with annual household income greater than $70,000 to continue hormonal therapy.
National Institutes of Health, NIH/National Cancer Institute

Contact: Garth Sundem
University of Colorado Anschutz Medical Campus

Public Release: 18-Nov-2015
Seminars in Cancer Biology
Plant and food-based compounds may be key to future cancer prevention
Rather than targeting one or two specific genes or proteins that contribute to cancer, the task force was charged with researching a broad-spectrum approach. 'This type of approach involves combinations of multiple low-toxicity agents that can collectively impact many pathways that are known to be important for the genesis and spread of cancer,' said Kumar.
Getting to Know Cancer

Contact: Steven Blanchard
H. Lee Moffitt Cancer Center & Research Institute

Showing releases 26-50 out of 1299.

<< < 1 | 2 | 3 | 4 | 5 | 6 > >>

  Search News Releases